Structural and functional changes by Ciprofloxacin of rat submandibular gland

Human and Experimental Toxicology

Volumn 22, Issue 4, 2003, Pages 177-181

  Abdollahi, Mohammad ^a   Minaiee, Bagher ^a   Yaaghoubi, Amir A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adverse effects; Ciprofloxacin; Fluoroquinolone; Rat; Salivary gland

Indexed keywords

AMYLASE; CALCIUM; CIPROFLOXACIN; CYCLIC AMP; DNA; ELECTROLYTE; POLYETHYLENE; POTASSIUM; PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM; SODIUM CHLORIDE;

ACINAR CELL; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL DAMAGE; CELL NUCLEUS; CELL WALL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DISSECTION; DNA SYNTHESIS; DOSE RESPONSE; ENZYME ACTIVITY; FLOW RATE; HISTOPATHOLOGY; MALE; MICROMORPHOLOGY; MICROSCOPE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SALIVA ANALYSIS; SALIVARY GLAND FUNCTION; STRUCTURE ANALYSIS; SUBMANDIBULAR GLAND;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; MODELS, ANIMAL; ORGAN SIZE; RATS; SALIVA; SUBMANDIBULAR GLAND;

ANIMALIA; VERTEBRATA;

EID: 0038633461     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327103ht350oa     Document Type: Article

References (31)

1. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001; 15 (Suppl 1): S9-S15.
2. Zhai S, Wei X, Parker BM, Kunze KL, Vestal RE. Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline. Ther Drug Monit 1996; 18: 666-71.
3. Piercy EA, Bawdon RE, Mackowiak PA. Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects. Antimicrob Agents Chemother 1989; 33: 1645-46.
4. Kozjek F, Suturkova LJ, Antolic G, Grabnar I, Mrhar A. Kinetics of 4-fluoroquinolones permeation into saliva. Biopharm Drug Dispos 1999; 20:183-91.
5. Smith A, Weber A, Pandher R, Williams-Warren J, Cohen ML, Ramsey B. Utilization of salivary concentrations of Ciprofloxacin in subjects with cystic fibrosis. Infection 1997; 25: 106-108.
6. Adler D, Maier H. Gyrase inhibitor Ciprofloxacin in human parotid saliva. J Clin Chem Clin Biochem 1989; 27: 232-33.
7. Maier H, Sziegoleit A, Merck S. Penetration of Ciprofloxacin into parotid gland tissue and parotid saliva. Arzneimittelforschung 1987; 37: 797-98.
8. Andriole VT. The future of quinolones. Drugs 1993; 45 (Suppl 3): 1-7.
9. Kelentey B, Kerr M, Tao Z, Purushotham KR, Humphreys-Beher MG, Zelles T. Inhibition of rat parotid gland growth response induced by chronic isoproterenol following treatment with quinolone antibiotics. Mol Cell Biochem 1996; 165: 55-63.
10. Baum BJ. Neurotransmitter control of secretion. J Dent Res 1987; 66: 628-32.
11. Edgar WM. Saliva: its secretion, composition and functions. Br Dent J 1992; 172: 305-12.
12. Abdollahi M., Isazadeh Z. Inhibition of rat parotid and submandibular gland functions by ofloxacin, a fluoroquinolone antibiotic. Fundam Clin Pharmacol 2001; 15: 307-11.
13. Ding G, Naora K, Nagasako S, Hirano H, Iwamoto K. Excretion of ofloxacin into saliva in rats with renal failure. J Pharmacol Exp Ther 1998; 287: 31-36.
14. Abdollahi M, AR Dehpour, Baharnouri G. Effects of rubidium on the secretory function of the rat submandibular gland. Toxic Subs Mech 1998; 17: 121-31.
15. Yoshida Y, Sprecher RL, Schneyer CA, Schneyer LH. Role of beta-receptors in sympathetic regulation of electrolytes in rat submaxillary saliva. Proc Soc Exp Biol Med 1967 126: 912-16.
16. - secretion rates relationship to a fluid generation mechanism. Jpn J Physiol 1970; 20: 540-49.
17. Lowry OH, Roserbrough NJ, Farr AL, Randell RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
18. Fernandez FJ, Kahn HL. Clinical methods for atomic absorption spectroscopy. Clin Chem Newslett 1971; 24: 190-95.
19. Bernfeld P. Enzymes of starch degradation and synthesis. Adv Enzymol 1951; 12: 379-428.
20. Munro HM, Fleck, A. 1966. The determination of nucleic acids. Methods Biochem Anal 14: 113-76.
21. Burton K. 1956. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem. J. 62: 315-23.
22. Waterborg JN, Mattheus HR. The Burton assay for DNA. In JM Walker ed. Methods in molecular biology, Vol. 2: Nucleic acids. Totawa, NJ: Humana Press Inc., 1994: 1-3.
23. Bailly S, Fay M, Roche Y, Gougerot-Pocidalo MA. Effects of quinolones on tumor necrosis factor production by human monocytes. Int J Immunopharmacol 1990; 12: 31-6.
24. MacGowan GA. Clinical overview of the novel inotropic agent toborinone. Expert Opin Investig Drugs 2000; 9: 1109-17.
25. Spratt TE, Schultz SS, Levy DE, Chen D, Schulter G, Williams GM. Different mechanisms for the photo-induced production of oxidative DNA damage by fluoroquinolones differing in photostability. Chem Res Toxicol 1999; 12: 809-15.
26. Schneyer CA. β-adrenergic effects by autonomic agents on mitosis and hypertrophy in rat parotid. Proc Soc Exp Biol Med 1969; 131: 71-75.
27. Abdollahi M, Sharifzadeh M, Marzban H, Abri G, Torab-Jahromi M. Alteration by lead acetate of rats submandibular gland morphology and ultrastructure. Toxic Subs Mech 1999; 18: 139-47.
28. Holtom PD, Pavkovic SA, Bravos PD, Patzakis MJ, Shepherd LE, Frenkel B. Inhibitory effects of the quinolone antibiotics trovafloxacin, Ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 2000; 18: 721-27.
29. Putney JW Jr. Identification of cellular activation mechanisms associated with salivary secretion. Annu Rev Physiol 1986; 48: 75-88.
30. Castle JD, Arvan P, Cameron R.. Protein production and secretion in exocrine cell. J Dent Res 1987; 66: 633-37.
31. Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50: 140-61.